Each Fourth of July, thousands of people are injured from using consumer fireworks. According to the U.S. Consumer Product Safety Commission, more than 9,000 fireworks-related injuries happen each year. Of these, nearly half are head-related injuries w…
Category: News
Positive results from RISE and RIDE Phase III trials of Genentech’s Lucentis for diabetic macular edema
Genentech, a member of the Roche Group, today announced 24-month results from the two pivotal Phase III trials (RISE and RIDE) assessing the efficacy and safety of Lucentis (ranibizumab injection) in people with diabetic macular edema (DME).
Neuroscientists Find Famous Optical Illusion Surprisingly Potent
Scientists have come up with new insight into the brain processes that cause the following optical illusion: The yellow jacket (Rocky, the mascot of the University of Rochester) appears to be expanding. But he is not. He is staying still. We simply…
LCA-Vision Announces Management Resignation
LCA-Vision Inc. , a leading provider of laser vision correction services under the LasikPlus® brand, today announced that Marcello J. Celentano has resigned as Senior Vice President of Operations effective July 11, 2011 to lead a company outside of th…
A Comparison of Ophthalmic Electronic Medical Record Systems
Technology Spotlight
Leave Fireworks To The Professionals This Fourth Of July: American Academy Of Ophthalmology Offers Tips For Fireworks Safety
Each Fourth of July, thousands of people are injured from using consumer fireworks. According to the U.S. Consumer Product Safety Commission, more than 9,000 fireworks-related injuries happen each year. Of these, nearly half are head-related injuries w…
Leave Fireworks To The Professionals This Fourth Of July: American Academy Of Ophthalmology Offers Tips For Fireworks Safety
Each Fourth of July, thousands of people are injured from using consumer fireworks. According to the U.S. Consumer Product Safety Commission, more than 9,000 fireworks-related injuries happen each year. Of these, nearly half are head-related injuries w…
Leave Fireworks To The Professionals This Fourth Of July: American Academy Of Ophthalmology Offers Tips For Fireworks Safety
Each Fourth of July, thousands of people are injured from using consumer fireworks. According to the U.S. Consumer Product Safety Commission, more than 9,000 fireworks-related injuries happen each year. Of these, nearly half are head-related injuries w…
ADA: Anti-VEGF ‘Impressive’ In Sharpening Vision
The good news continues to roll in for ranibizumab (Lucentis) in diabetic macular edema with positive results from the RIDE and RISE trials.
Mimetogen Pharmaceuticals Inc. Announces Positive Top Line Data From Phase II Clinical Trial Of MIM-D3 For Dry Eye Disease
Mimetogen Pharmaceuticals Inc. (“Mimetogen”) today announced positive top line data from a Phase II clinical trial with MIM-D3, its lead drug for the treatment of dry eye. The trial demonstrated statistically significant improvements in signs and sympt…
ADA: Anti-VEGF ‘Impressive’ in Sharpening Vision (CME/CE, with video)
SAN DIEGO (MedPage Today) — The good news continues to roll in for ranibizumab (Lucentis) in diabetic macular edema with positive RIDE and RISE trial results.
Mimetogen Pharmaceuticals Inc. Announces Positive Top Line Data From Phase II Clinical Trial Of MIM-D3 For Dry Eye Disease
Mimetogen Pharmaceuticals Inc. (“Mimetogen”) today announced positive top line data from a Phase II clinical trial with MIM-D3, its lead drug for the treatment of dry eye. The trial demonstrated statistically significant improvements in signs and sympt…
BCVA Stabilizes With As-Needed Anti-VEGF
A low number of anti-VEGF injections in patients with neovascular age-related macular degeneration produced positive results after 1 year of treatment, but the results fell short of the efficacy associated with more frequent injections, according to a …
EYLEAT (aflibercept Injection) Submitted In Japan For Marketing Authorization For The Treatment Of Wet Age-Related Macular Degeneration
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced thatBayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEAT, also known as …
The Revolutionary Training Tool For Cataract Surgery
The Kitaro DryLab and WetLab Kits are revolutionary educational and training tools for cataract surgery. These innovative kits offer realistic surgical simulation through specially designed synthetic materials that give the look and feel of the natural…
Reichert Technologies Launches New Advantage Plus Chair And Stand
Reichert Technologies is pleased to announce the release of their new Advantage Plus Chair and Stand. The Advantage Plus unit features the same robust construction as the original Advantage Chair and Stand, which has successfully served the eye care co…
Study Links Celiac Disease to Cataract Risk
People with celiac disease may have a slightly increased risk of cataracts, a new study suggests. Reuters Health Information
Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML
Over a decade ago, Canadian patients diagnosed with chronic myeloid leukemia (CML), celebrated when PrGleevec (imatinib mesylate) was approved in Canada.
STAAR Surgical completes first procedures to implant Visian ICL V4c design
STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive refractive lenses that go inside the eye, today announced the completion of the first procedures to implant its recently CE Mark-approved Visian Implantable …
ACT Granted EU Orphan Medicinal Product Designation For HESC-Derived RPE Cells For Treatment Of Stargardt’s Disease
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today that the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has officially granted ACT’s human embryonic stem cell (hESC)-der…